MedMira Reports Third Quarter Results FY2023
HALIFAX, NS / ACCESSWIRE / June 29, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2023. Corporate Update Summary During the third ...
- Supported exchanges /
- F /
- 47M.F
MedMira Inc (47M F) stock market data APIs
€0.0445
0(0%)
as of October 28, 2024
Price chart is built with Anychart
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. In addition, the company offers VYRATM TriDemic antigen rapid test that distinguishes the three respiratory viruses, such as SARS-CoV-2, influenza, and respiratory syncytial virus that exhibit similar symptoms. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
MedMira Inc Financial Data Overview
| 0.0445 | |
| 0.0445 | |
| - | |
| 0.0445 | |
| 0.0445 | |
| 0.0425-0.0845 | |
| 42 884 K | |
| 702 M | |
| 383 K | |
| 10.662 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'47M',
Type:
'Common Stock',
Name:
'MedMira Inc',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
'CA58501R1029',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'July',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
MedMira Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 383 K
- EBITDA -2 118 960
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get MedMira Inc Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get MedMira Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get MedMira Inc latest news via APIs
MedMira Second Quarter 2023 Earnings: CA$0.001 loss per share (vs CA$0.001 loss in 2Q 2022)
MedMira (CVE:MIR) Second Quarter 2023 Results Key Financial Results Revenue: CA$170.5k (down 43% from 2Q 2022). Net loss: CA$490.5k (loss widened by 4.7% from 2Q 2022). CA$0.001 loss per share (in l...
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
